Literature DB >> 7751017

Genetic restriction and specificity of the immune response in mice to fusion proteins containing repeated sequences of the Plasmodium falciparum antigen Pf155/RESA.

A Sjölander1, R Andersson, M Hansson, K Berzins, P Perlmann.   

Abstract

The genetic restriction and specificity of the immune response in mice to two fusion proteins, ZZ-M3 and ZZ-M5, were studied. These proteins contain two IgG-binding domains (ZZ) from staphylococcal protein A, and repeated sequences from the C-terminal [(VEHDAEEN)5 (VEEN)10] (M3) or central [(VEEPTVADDEH)3(VEEPTVAEEH)2] (M5) regions of the Plasmodium falciparum malaria blood stage antigen Pf155/RESA. Strong antibody and T-cell responses to M3 and M5 were linked to expression of the I-Ak allele, and T-cell responses to the bacterial fusion partner ZZ were restricted to mice of the H-2k haplotype. The response to M5 was less restricted than that to M3, giving intermediate responses in mice of H-2d haplotypes as well. However, ZZ-M5-primed lymph node (LN) cells from these mice were primarily induced to proliferate in vitro by the complete ZZ-M5 construct and not by synthetic peptides representing the repeated subunits in M5. The reactivity with intact Pf155/RESA in erythrocyte membrane immunofluorescence was weak of antisera from mice immunized with ZZ-M5, whereas the reactivity of antisera from mice immunized with ZZ-M3 roughly paralleled their reactivity with M3 in an enzyme-linked immunosorbent assay (ELISA). The antibody responses induced by immunization with ZZ-M3 or ZZ-M5 were specific for M3 or M5, respectively, while activated T cells displayed cross-reactivity between M3 and M5 in an in vitro proliferation assay. The results indicate that the assembly of repeated sequences in fusion proteins affects both the MHC class II restriction and the specificity of the induced antibody and T-cell responses.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7751017      PMCID: PMC1415139     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  26 in total

1.  Target antigens for asexual malaria vaccine development.

Authors:  R J Howard; B L Pasloske
Journal:  Parasitol Today       Date:  1993-10

2.  Mechanisms of T cell recognition with application to vaccine design.

Authors:  J A Berzofsky
Journal:  Mol Immunol       Date:  1991-03       Impact factor: 4.407

3.  Class II restriction in mice to the malaria candidate vaccine ring infected erythrocyte surface antigen (RESA) as synthetic peptides or as expressed in recombinant vaccinia.

Authors:  A M Lew; C J Langford; D Pye; S Edwards; L Corcoran; R F Anders
Journal:  J Immunol       Date:  1989-06-01       Impact factor: 5.422

4.  Passive immunization of Aotus monkeys with human antibodies to the Plasmodium falciparum antigen Pf155/RESA.

Authors:  K Berzins; H Perlmann; B Wåhlin; H P Ekre; B Högh; E Petersen; B Wellde; M Schoenbechler; J Williams; J Chulay
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

5.  Human immune response in Plasmodium falciparum malaria. Synthetic peptides corresponding to known epitopes of the Pf155/RESA antigen induce production of parasite-specific antibodies in vitro.

Authors:  C Chougnet; M Troye-Blomberg; P Deloron; L Kabilan; J P Lepers; J Savel; P Perlmann
Journal:  J Immunol       Date:  1991-10-01       Impact factor: 5.422

6.  Immune sera recognize on erythrocytes Plasmodium falciparum antigen composed of repeated amino acid sequences.

Authors:  R L Coppel; A F Cowman; R F Anders; A E Bianco; R B Saint; K R Lingelbach; D J Kemp; G V Brown
Journal:  Nature       Date:  1984 Aug 30-Sep 5       Impact factor: 49.962

7.  Immune response in mouse and malaria-exposed humans to peptides derived from Pf11-1, a highly repetitive megadalton protein of Plasmodium falciparum.

Authors:  A Scherf; C Behr; J L Sarthou; M Pla; C Rogier; J F Trape; L P da Silva; P Dubois
Journal:  Eur J Immunol       Date:  1993-07       Impact factor: 5.532

8.  The Pf332 gene of Plasmodium falciparum codes for a giant protein that is translocated from the parasite to the membrane of infected erythrocytes.

Authors:  D Mattei; A Scherf
Journal:  Gene       Date:  1992-01-02       Impact factor: 3.688

9.  Immunogenicity in rabbits and monkeys of influenza ISCOMs conjugated with repeated sequences of the Plasmodium falciparum antigen Pf155/RESA.

Authors:  A Sjölander; M Hansson; K Lövgren; B Wåhlin; K Berzins; P Perlmann
Journal:  Parasite Immunol       Date:  1993-06       Impact factor: 2.280

Review 10.  Malaria vaccines: immunogen selection and epitope mapping.

Authors:  P Perlmann; K Berzins; H Perlmann; M Troye-Blomberg; M Wahlgren; B Wåhlin
Journal:  Vaccine       Date:  1988-04       Impact factor: 3.641

View more
  1 in total

1.  Purification, characterization, and immunogenicity of a disulfide cross-linked Plasmodium vivax vaccine candidate antigen, merozoite surface protein 1, expressed in Escherichia coli.

Authors:  S Dutta; L A Ware; A Barbosa; C F Ockenhouse; D E Lanar
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.